Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-24 @ 2:44 PM
NCT ID:
NCT02543359
Eligibility Criteria:
Inclusion Criteria:
Administrators group
* must be employed at an agency selected to participate in training as an Executive Director, Chief Financial Officer, or other person responsible for daily operations.
Clinicians/Supervisors group
* a masters or doctoral level professional in the human services field (e.g., social work, psychology, education),
* licensed in his/her field or receiving supervision from a licensed individual,
* actively seeing children and families who are appropriate for PCIT,
* receptive to training in PCIT but not previously trained in PCIT,
* amenable to study tasks (e.g., video-taping, completing assessments).
Parent-Child Dyads group
* Any parent-child dyad who a trained clinician enrolls in PCIT services
Exclusion Criteria:
Administrators group
* not employed at an agency selected to participate in training as an Executive Director, Chief Financial Officer, or other person responsible for daily operations.
Clinicians group
* a bachelors or lower level professional in the human services field,
* unlicensed in his/her field or not receiving supervision from a licensed individual,
* not actively seeing children and families who are appropriate for PCIT,
* not receptive to training in PCIT but not previously trained in PCIT, and/or
* not amenable to study tasks. Interns also will be excluded.
Parent-Child Dyads group
\- if he/she is a ward of the state or living in state custody
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT02543359
Study Brief:
Protocol Section:
NCT02543359